The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...
An experimental gene therapy developed by researchers at UCLA, University College London and Great Ormond Street Hospital has ...
Developed by Paris, France-based EssilorLuxottica and made for children as young as 6, the brand-new Stellest lenses slow the progression of myopia.
The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, ...
Watch as Gabe Fholer rings the bell to celebrate being cancer-free. Doctors say a breakthrough drug helped make it happen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback